TTD | Drug: D0YM7U

Drug General Information
Drug ID	D0YM7U
Former ID	DCL000627
Drug Name	Rituxan Hemotalogy/oncology
Drug Type	Antibody
Indication	Non-hodgkin's lymphoma [ICD10:C85]		Approved	[544126]
Company	Genentech
Target and Pathway
Target(s)	B-lymphocyte antigen CD20	Target Info		[550797]
KEGG Pathway	Hematopoietic cell lineage
References
Ref 544126	Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin's Lymphoma. P T. 2010 March; 35(3): 148-157.
Ref 550797	Clinical pipeline report, company report or official report of Genentech (2009).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information